Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Society
Taiwanese drug manufacturer deported from Philippines after jail term
03/11/2026 10:16 PM -
Society
Two found dead after fire in Tainan
03/11/2026 10:03 PM -
Society
Australian man testifies in rat poison attempted murder case
03/11/2026 09:51 PM -
Business
Taiwan ranks 5th globally in 2026 economic freedom index
03/11/2026 09:08 PM -
Society
Highway Bureau targets late April fix for Danjiang Bridge noise
03/11/2026 07:46 PM